117 related articles for article (PubMed ID: 19222454)
1. Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
Lee JH; Cheng AL; Lin CW; Kuo SH
Br J Dermatol; 2009 Apr; 160(4):887-9. PubMed ID: 19222454
[No Abstract] [Full Text] [Related]
2. Primary cutaneous anaplastic large cell lymphoma successfully treated with low-dose oral methotrexate.
Fujita H; Nagatani T; Miyazawa M; Wada H; Koiwa K; Komatsu H; Ikezawa Z
Eur J Dermatol; 2008; 18(3):360-1. PubMed ID: 18474486
[No Abstract] [Full Text] [Related]
3. Regression of CD30+ cutaneous anaplastic large-cell lymphoma with denileukin diftitox.
Dao H; Barr PM; Honda K
J Am Acad Dermatol; 2011 Jun; 64(6):e123-5. PubMed ID: 21571160
[No Abstract] [Full Text] [Related]
4. Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.
Yamane N; Kato N; Nishimura M; Ito M; Yanagi T; Osawa R
Clin Exp Dermatol; 2009 Jul; 34(5):e56-9. PubMed ID: 19438576
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
Kong YY; Dai B; Kong JC; Lu HF; Shi DR
Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
[TBL] [Abstract][Full Text] [Related]
6. Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin.
Desai A; Telang GH; Olszewski AJ
Ann Hematol; 2013 Apr; 92(4):567-8. PubMed ID: 23086510
[No Abstract] [Full Text] [Related]
7. Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate.
Nakamura S; Hashimoto Y; Nishi K; Mizumoto T; Takahashi H; Iizuka H
Eur J Dermatol; 2012; 22(5):709-10. PubMed ID: 22929532
[No Abstract] [Full Text] [Related]
8. Anaplastic large-cell T-cell lymphoma.
Stein JA; Soldano AC; Latkowski JA
Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous CD30-positive anaplastic large cell lymphoma in an 80-year-old man: a case report from Nepal.
Parajuli S; Gurung D; Paudel U; Pokhrel DB; Kempf W
Int J Dermatol; 2014 Dec; 53(12):1498-500. PubMed ID: 24738699
[No Abstract] [Full Text] [Related]
10. Primary cutaneous CD30+ anaplastic large-cell lymphomas mimicking keratoacanthomas.
Martín JM; Ricart JM; Monteagudo C; Alcácer J; Pinazo I; Tomás L; Rausell N; Jordá E
Clin Exp Dermatol; 2007 Nov; 32(6):668-71. PubMed ID: 17953637
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma.
Laly P; Ingen-Housz-Oro S; Beylot-Barry M; Verneuil L; Adamski H; Brice P; Bagot M
JAMA Dermatol; 2015 Sep; 151(9):1030-1. PubMed ID: 26108120
[No Abstract] [Full Text] [Related]
12. CD30-positive primary cutaneous anaplastic large-cell lymphoma and definite squamous cell carcinoma.
Yanagi T; Shimizu T; Kodama K; Nemoto-Hasebe I; Kasai M; Shimizu H
Clin Exp Dermatol; 2009 Oct; 34(7):e293-4. PubMed ID: 19456793
[No Abstract] [Full Text] [Related]
13. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
[TBL] [Abstract][Full Text] [Related]
14. Complete Resolution of Primary Cutaneous Anaplastic Large Cell Lymphoma With Topical Imiquimod.
Kubicki SL; Park KE; Aung PP; Duvic M
J Drugs Dermatol; 2019 May; 18(5):460-462. PubMed ID: 31141854
[TBL] [Abstract][Full Text] [Related]
15. CD30-positive primary cutaneous anaplastic large cell lymphoma with coexistent pseudocarcinomatous hyperplasia.
Kreuter A; Pantelaki I; Michalowitz AL; Wieland U; Cerroni L; Oellig F; Tigges C
Clin Exp Dermatol; 2018 Jul; 43(5):585-588. PubMed ID: 29473196
[TBL] [Abstract][Full Text] [Related]
16. RF - Brentuximab as Treatment for CD30
Morgado-Carrasco D; Combalia A; Estrach Panella T
Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):769-770. PubMed ID: 31151669
[No Abstract] [Full Text] [Related]
17. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
Abasq C; Duval-Modeste AB; Courville P; Joly P
Ann Dermatol Venereol; 2008; 135(6-7):509-11. PubMed ID: 18598807
[No Abstract] [Full Text] [Related]
18. Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
Aldaoud A
Dermatol Clin; 2008 Jan; 26 Suppl 1():15-7. PubMed ID: 18405181
[No Abstract] [Full Text] [Related]
19. A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma.
Shah M; Pawar M; Zawar V
Acta Dermatovenerol Alp Pannonica Adriat; 2018 Mar; 27(1):33-34. PubMed ID: 29589643
[TBL] [Abstract][Full Text] [Related]
20. [Skin involvement as the presenting feature of primary systemic anaplastic lymphoma kinase-negative CD30+ anaplastic lymphoma].
Messeguer F; Requena C; Traves V; Lorente P; Guillén-Barona C
Actas Dermosifiliogr; 2011 Sep; 102(7):547-8. PubMed ID: 21530929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
